Factors influencing endometrial cancer mortality: The Western Pennsylvania Registry

Future Oncology

Volumn 4, Issue 6, 2008, Pages 857-865

  Linkov, Faina ^a   Taioli, Emanuela ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Endometrial carcinoma; Registry; Survival analysis; Uterus

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN; PROGESTERONE; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER GRADING; CANCER MORTALITY; CANCER REGISTRY; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CASE CONTROL STUDY; CAUCASIAN; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; MORBIDITY; PARITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; UNITED STATES; ENDOMETRIUM TUMOR; GYNECOLOGIC SURGERY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PREGNANCY; RACE; REGISTER;

ANTINEOPLASTIC AGENTS; CONTINENTAL POPULATION GROUPS; ENDOMETRIAL NEOPLASMS; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; PARITY; PENNSYLVANIA; PREGNANCY; REGISTRIES; RISK FACTORS;

EID: 61449375187     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.6.857     Document Type: Article

References (21)

1. Mishell DR Jr, Droegemueller W, Herbst AL: Comprehensive Gynecology (3rd Edition). Mosby, St Louis, MO, USA (1997).
2. Ries LAG, Eisner MP, Kosary CL et al. (Eds): SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda, MD, USA (2002).
3. Ries LAG, Melbert D, Krapcho M et al. (Eds): Endometrial cancer. In: SEER Cancer Statistics Review, 1975-2005. National Cancer Institute. Bethesda, MD, USA (2008).
4. Ueda SM, Kapp DS, Cheung MK, et al.: Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am. J. Obstet. Gynecol. 198, 218 (2008).
5. Hu FB: Overweight and obesity in women: health risks and consequences. J. Womens Health (Larchmt) 12(2), 163-172 (2003).
6. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM: Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int. J. Gynecol. Cancer 17(2), 441-446 (2007).
7. Jolly S, Vargas CE, Kumar T et al.: The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Gynecol. Oncol. 103(1), 87-93 (2006).
8. Pipino LL LY, Wang RY: Data quality assessment. Commun. ACM 45(4), 211-218 (2002).
9. Farley JH, Nycum LR, Bitter MJ, Park RC, Taylor RR: Age-specific survival of women with endometrioid adenocarcinoma of the uterus. Gynecol. Oncol. 79(1), 86-89 (2000).
10. Fleisch MC, Pantke P, Beckmann MW et al.: Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J. Surg. Oncol. 95(6), 476-484 (2007).
11. Sherman ME, Devesa SS: Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer 98(1), 176-186 (2003).
12. Connell PP, Rotmensch J, Waggoner SE, Mundt AJ: Race and clinical outcome in endometrial carcinoma. Obstet. Gynecol. 94(5 Pt 1), 713-720 (1999).
13. Nathan H, Pawlik TM: Limitations of claims and registry data in surgical oncology research. Ann. Surg. Oncol. 15(2), 415-423 (2008).
14. Diehr P, Williamson J, Patrick DL, Bild DE, Burke GL: Patterns of self-rated health in older adults before and after sentinel health events. J. Am. Geriatr. Soc. 49(1), 36-44 (2001).
15. Kosary CL: FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10(1), 31-46 (1994).
16. Webster LA, Weiss NS: Alcoholic beverage consumption and the risk of endometrial cancer. Cancer and Steroid Hormone Study Group. Int. J. Epidemiol. 18(4), 786-791 (1989).
17. Bandera EV, Kushi LH, Olson SH, Chen WY, Muti P: Alcohol consumption and endometrial cancer: some unresolved issues. Nutr. Cancer 450), 24-29 (2003).
18. Temkin SM, Pezzullo JC, Hellmann M, Lee YC, Abulafia O: Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am. J. Clin. Oncol. 30(1), 8-14 (2007).
19. Anderson B, Connor JP, Andrews JI et al.: Obesity and prognosis in endometrial cancer. Am. J. Obstet. Gynecol. 174(4), 1171-1178; discussion 1178-1179 (1996).
20. Everett E, Tamimi H, Greer B et al.: The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol. Oncol. 90(1), 150-157 (2003).
21. Jadoul P, Donnez; J: Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia of endometrial adenocarcinoma. Fertil. Steril. 80(6), 1315-1324 (2003).